{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-024727","form_type":"8-K","ticker":"TVGN","cik":"0001860871","company_name":"Tevogen Bio Holdings Inc.","filed_at":"2024-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.948523+00:00","generated_at":"2026-06-01T03:01:49.183295+00:00","sec_items":["1.01","1.02","3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Tevogen Bio receives Nasdaq bid price deficiency notice, repurchases Series B Preferred Stock","bullets":["Received Nasdaq letter on June 14, 2024, for non-compliance with $1.00 minimum bid price rule for 35 consecutive business days.","Company has 180 days until December 11, 2024, to regain compliance by closing bid price at $1.00 or more for 10 consecutive days.","Repurchased all 3,613 shares of Series B Preferred Stock from SSVK Associates LLC on June 15, 2024, reassuming $3.6 million liabilities.","Suren Ajjarapu, managing member of SSVK, is a board member; SSVK owns over 5% of common stock.","Repurchase cancelled all outstanding Series B Preferred Stock; related Assignment and Assumption Agreement terminated."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-024727","json":"https://secwatch.observer/filing/0001493152-24-024727.json","markdown":"https://secwatch.observer/filing/0001493152-24-024727.md","text":"https://secwatch.observer/filing/0001493152-24-024727.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860871/000149315224024727/0001493152-24-024727-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860871/000149315224024727/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T03:01:49.183295+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}